Results
|
1.
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Francis
- Garcia, Carlos
- Van Nostrand, Douglas
Year: 2017
Citation: - Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
Medline publication type:
All authors: - Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
|
|
2.
|
|
|
3.
|
|
|
4.
|
Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer. MedStar authors:
- Atkins, Francis
- Burman, Kenneth D
- Garcia, Carlos
- Kulkarni, Kanchan
- Plyku, Donika
- Tefera, Eshetu
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
Year: 2021
Citation: - Clinical Nuclear Medicine. 2021 Jan 21
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
All authors: - Atkins F, Burman KD, Garcia C, Kulkarni K, Plyku D, Tefera E, Van Nostrand D, Wartofsky L, Wu D
|
|
5.
|
Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors:
- Atkins, Francis
- Burman, Kenneth
- Garcia, Carlos
- Khorjekar, Gauri R
- Mete, Mihriye
- Moreau, Shari
- O'Neil, Jeff
- Orquiza, Michael H
- Van Nostrand, Douglas
- Wartofsky, Leonard
Citation: - Thyroid. 24(9):1394-9, 2014 Sep.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L
|